YD Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
YD Bio Limited income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022
Period EndingDec 2024Dec 2023Dec 2022
Revenue & Gross Profit
Revenue0.510.350.36
Cost of Revenue0.360.200.23
Gross Profit0.160.150.13
Operating Expenses
Research & Development0.490.000.00
Selling, General & Administrative1.130.160.18
Operating Expenses1.620.160.18
Operating Income-1.46-0.01-0.04
Other Income/Expense
Interest Income0.010.000.00
Interest Expense0.000.000.00
Other Income/Expense0.080.030.06
Income
Income Before Tax-1.390.02-0.05
Income Tax Expense0.030.000.00
Net Income-1.410.01-0.05
Net Income - Continuous Operations-1.410.010.00
Net Income - Discontinued Operations0.000.000.00
EBITDA-1.280.02-0.04
EBIT-1.460.02-0.04
Depreciation & Amortization0.100.000.00
Earnings Per Share
Basic EPS-1.00--
Diluted EPS-1.00--
Basic Shares Outstanding4.1570.100.00
Diluted Shares Outstanding4.1570.100.00